Markus Mayrhofer

Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Petersson, Alexandra; Svensson, Maja; Hau, Sofie Olsson; Bergstrom, Rebecka et al.

Ingår i Scientific Reports, 2025

• DOI för Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
• Ladda ner fulltext (pdf) av Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Martling, Anna; Hed Myrberg, Ida; Nilbert, Mef; Grönberg, Henrik et al.

Ingår i New England Journal of Medicine, s. 1051-1064, 2025

• DOI för Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit et al.

Ingår i Nature Medicine, 2024

• DOI för Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
• Ladda ner fulltext (pdf) av Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Öfverholm, Ingegerd; Lin, Yingbo; Mondini, Julia; Hardingz, John et al.

Ingår i Cancers, 2024

• DOI för Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors
• Ladda ner fulltext (pdf) av Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

Öfverholm, Ingegerd; Wallander, Karin; Haglund, Cecilia; Chellappa, Venkatesh et al.

Ingår i Clinical Cancer Research, s. 2647-2658, 2024

• DOI för Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Petersson, Alexandra; Svensson, Maja; Hau, Sofie Olsson; Bergstrom, Rebecka et al.

Ingår i Scientific Reports, 2025

• DOI för Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
• Ladda ner fulltext (pdf) av Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Martling, Anna; Hed Myrberg, Ida; Nilbert, Mef; Grönberg, Henrik et al.

Ingår i New England Journal of Medicine, s. 1051-1064, 2025

• DOI för Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit et al.

Ingår i Nature Medicine, 2024

• DOI för Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
• Ladda ner fulltext (pdf) av Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Öfverholm, Ingegerd; Lin, Yingbo; Mondini, Julia; Hardingz, John et al.

Ingår i Cancers, 2024

• DOI för Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors
• Ladda ner fulltext (pdf) av Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

Öfverholm, Ingegerd; Wallander, Karin; Haglund, Cecilia; Chellappa, Venkatesh et al.

Ingår i Clinical Cancer Research, s. 2647-2658, 2024

• DOI för Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden

de Ståhl, Teresita Diaz; Shamikh, Alia; Mayrhofer, Markus; Juhos, Szilvester et al.

Ingår i Journal of Translational Medicine, 2023

• DOI för The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
• Ladda ner fulltext (pdf) av The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Ingår i Blood Advances, s. 152-164, 2022

• DOI för Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
• Ladda ner fulltext (pdf) av Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Ingår i Blood Advances, s. 900-912, 2021

• DOI för Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages

Baskaran, Sathishkumar; Mayrhofer, Markus; Göransson Kultima, Hanna; Bergström, Tobias et al.

Ingår i Neuro-Oncology, s. 1080-1091, 2018

• DOI för Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages
• Ladda ner fulltext (pdf) av Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages

Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Mathot, Lucy; Kundu, Snehangshu; Ljungström, Viktor; Svedlund, Jessica et al.

Ingår i Cancer Research, s. 1730-1740, 2017

• DOI för Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Genetic Heterogeneity in Rhabdomyosarcoma Revealed by SNP Array Analysis

Walther, Charles; Mayrhofer, Markus; Nilsson, Jenny; Hofvander, Jakob et al.

Ingår i Genes, Chromosomes and Cancer, s. 3-15, 2016

• DOI för Genetic Heterogeneity in Rhabdomyosarcoma Revealed by SNP Array Analysis

Rawcopy: Improved copy number analysis with Affymetrix arrays

Mayrhofer, Markus; Viklund, Björn; Isaksson, Anders

Ingår i Scientific Reports, 2016

• DOI för Rawcopy: Improved copy number analysis with Affymetrix arrays
• Ladda ner fulltext (pdf) av Rawcopy: Improved copy number analysis with Affymetrix arrays

Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer

Mengelbier, Linda Holmquist; Karlsson, Jenny; Lindgren, David; Valind, Anders et al.

Ingår i Nature Communications, 2015

• DOI för Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Birgisson, Helgi; Edlund, Karolina; Wallin, Ulrik; Påhlman, Lars et al.

Ingår i BMC Cancer, 2015

• DOI för Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
• Ladda ner fulltext (pdf) av Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.

Crona, Joakim; Backman, Samuel; Maharjan, Rajani; Mayrhofer, Markus et al.

Ingår i Clinical Cancer Research, s. 4451-4460, 2015

• DOI för Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

Watkins, Johnathan; Weekes, Daniel; Shah, Vandna; Gazinska, Patrycja et al.

Ingår i Cancer Discovery, s. 488-505, 2015

• DOI för Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Mayrhofer, Markus; Kultima, Hanna Göransson; Birgisson, Helgi; Sundström, Magnus et al.

Ingår i BMC Cancer, s. 872, 2014

• DOI för 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
• Ladda ner fulltext (pdf) av 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue

Mayrhofer, Markus; DiLorenzo, Sebastian; Isaksson, Anders

Ingår i Genome Biology, 2013

• DOI för Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue
• Ladda ner fulltext (pdf) av Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Skírnisdóttir, Ingiridur; Mayrhofer, Markus; Rydåker, Maria; Åkerud, Helena et al.

Ingår i BMC Cancer, s. 407, 2012

• DOI för Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease
• Ladda ner fulltext (pdf) av Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia

Mansouri, Larry; Gunnarsson, Rebeqa; Sutton, Lesley-Ann; Ameur, Adam et al.

Ingår i American Journal of Hematology, s. 737-740, 2012

• DOI för Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Rasmussen, Markus; Sundström, Magnus; Kultima, Hanna Göransson; Botling, Johan et al.

Ingår i Genome Biology, 2011

• DOI för Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
• Ladda ner fulltext (pdf) av Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

Gunnarsson, Rebeqa; Mansouri, Larry; Isaksson, Anders; Göransson, Hanna et al.

Ingår i Haematologica, s. 1161-1169, 2011

• DOI för Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors

Marincevic, Millaray; Cahill, Nicola; Isaksson, Anders; Mansouri, Mahmoud Reza et al.

Ingår i Haematologica, s. 1519-1525, 2010

• DOI för High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors

Characterization of the RNA content of chromatin

Mondal, Tanmoy; Rasmussen, Markus; Pandey, Gaurav Kumar; Isaksson, Anders et al.

Ingår i Genome Research, s. 899-907, 2010

• DOI för Characterization of the RNA content of chromatin

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

Gunnarsson, R.; Isaksson, Anders; Mansouri, Mahmoud; Göransson, H. et al.

Ingår i Leukemia, s. 211-215, 2010

• DOI för Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data

Göransson, Hanna; Edlund, Karolina; Rydåker, Maria; Rasmussen, Markus et al.

Ingår i PloS one, 2009

• DOI för Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data

SUPPLEMENTARY MATERIAL: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2021

SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2020

• Ladda ner fulltext (pdf) av SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Copy Number Analysis of Cancer

Mayrhofer, Markus

2015

• Ladda ner fulltext (pdf) av Copy Number Analysis of Cancer